Withdraw all COX-2-selective drugs

Simple item page
dc.contributor.authorMansfield, P.
dc.contributor.authorVitry, A.
dc.contributor.authorWright, J.
dc.date.issued2005
dc.description.statementofresponsibilityPeter R Mansfield, Agnés I Vitry and James M Wright
dc.identifier.citationMedical Journal of Australia, 2005; 182(4):197-197
dc.identifier.doi10.5694/j.1326-5377.2005.tb06654.x
dc.identifier.issn0025-729X
dc.identifier.issn1326-5377
dc.identifier.orcidMansfield, P. [0009-0006-6697-8687]
dc.identifier.urihttp://hdl.handle.net/2440/48163
dc.language.isoen
dc.publisherAustralasian Med Publ Co Ltd
dc.source.urihttp://www.mja.com.au/public/issues/182_04_210205/matters_arising_210205_fm-1.html
dc.subjectHumans
dc.subjectCardiovascular Diseases
dc.subjectProduct Surveillance, Postmarketing
dc.subjectDrug and Narcotic Control
dc.subjectCyclooxygenase 2 Inhibitors
dc.titleWithdraw all COX-2-selective drugs
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

General Practice publications